Features | Partner Sites | Information | LinkXpress
Sign In
BioConferenceLive
GLOBETECH PUBLISHING
JIB

Sample Card Punching Workstation Provides High-Throughput Sample Prep

By BiotechDaily International staff writers
Posted on 22 Nov 2012
Image: The easyPunch STARlet workstation (Photo courtesy of Hamilton Robotics).
Image: The easyPunch STARlet workstation (Photo courtesy of Hamilton Robotics).
A new laboratory workstation has been developed to minimize human error and enables high-throughput sample preparation for a range of applications, such as forensic reference databasing as well as preclinical and clinical drug metabolism and pharmacokinetics (DMPK) and toxicology studies.

Hamilton Robotics (Reno, NV, USA) in collaboration with GE Healthcare (Chalfont St. Giles, UK) Life Sciences introduces the easyPunch STARlet workstation, the first fully automated system integrating sample card punching and liquid handling into one easy workflow.

The easyPunch STARlet system, made in Hamilton’s Bonaduz (Switzerland) facility, incorporates punching of GE Healthcare Whatman FTA and DMPK sample collection cards with automated sample extraction, eliminating typical logjams in laboratory processes.

“Because many labs lack a fully automated workflow, thousands of samples such as blood and saliva placed on punch cards are waiting long periods to be processed for critical studies and forensic analysis,” said Stefan Mauch, product manager of the easyPunch STARlet system. “Until now, sample card punching for analysis preparation required tedious manual work or separate semiautomated instruments and an operator. Researchers or technicians had to be consistently precise and experienced when handling and tracking samples, or the results could be compromised.”

The easyPunch workstation is based on the Hamilton Robotics Microlab STARlet platform and features two special modules and robotic arms for transporting and punching paper cards. The samples are monitored by effective tracking software to remove any risk of sample identification errors. The total process is tracked using imaging recognition. Hamilton’s proprietary software, based on industrial machine vision technology, provides complete control and monitoring of the punching process. The software recognizes the position and size of the card, identifies the sample by reading the barcode, and determines the punch area. The workstation also takes a picture of the target well to ensure the punch has arrived in the designated well.

Compatibility with library information-management systems (LIMS) and full traceability ensure that data can be linked effectively to each sample. The modular nature of the system enables incorporation of other devices, such as a centrifuge and a plate sealer, thus potentially integrating the entire workflow.

“Ease of use makes this workstation an attractive solution for repetitive tasks in forensic and biopharma sample handling,” remarked Navjot Kaur, product manager at Hamilton Robotics in Reno, Nevada. “Currently technicians manually clean between samples, but the easyPunch STARlet system performs this step automatically, reducing cross-contamination. Barcode reading and imaging support full traceability and reporting of samples, both during punching and downstream processing.”

Hamilton Company is a global leader in the development and manufacture of process measurement, liquid handling, robotics and storage solutions, serving customers in academic and private research laboratories, pharmaceutical, and clinical diagnostic companies and government institutions.

Related Links:

Hamilton Robotics
GE Healthcare




comments powered by Disqus

Channels

Drug Discovery

view channel
Image: The European Commission has approved the use of Avastin combined with chemotherapy as a treatment for women with recurrent ovarian cancer (Photo courtesy of Genentech).

Drug for Treatment of Platinum Resistant Recurrent Ovarian Cancer Approved for Use in Europe

For the first time in more than 15 years the European Commission (EC) has approved a new therapeutic option for the most difficult to treat form of ovarian cancer. Ovarian cancer causes more deaths... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Business

view channel

Global Computational Biology Sector Expected to Reach over USD 4 Billion by 2020

The global market for computational biology is expected to reach USD 4.285 billion by 2020 growing at a compound annual growth rate (CAGR) of 21.1%, according to new market research. Steady surge in the usage and application of computational biology for bioinformatics R&D programs designed for sequencing genomes... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.